1. Home
  2. GNLX vs RZLT Comparison

GNLX vs RZLT Comparison

Compare GNLX & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • RZLT
  • Stock Information
  • Founded
  • GNLX 2001
  • RZLT 2010
  • Country
  • GNLX United States
  • RZLT United States
  • Employees
  • GNLX 24
  • RZLT N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNLX Health Care
  • RZLT Health Care
  • Exchange
  • GNLX Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • GNLX 103.6M
  • RZLT 303.1M
  • IPO Year
  • GNLX 2023
  • RZLT N/A
  • Fundamental
  • Price
  • GNLX $2.95
  • RZLT $5.72
  • Analyst Decision
  • GNLX Strong Buy
  • RZLT Strong Buy
  • Analyst Count
  • GNLX 4
  • RZLT 8
  • Target Price
  • GNLX $18.75
  • RZLT $11.63
  • AVG Volume (30 Days)
  • GNLX 172.3K
  • RZLT 435.9K
  • Earning Date
  • GNLX 11-19-2024
  • RZLT 11-07-2024
  • Dividend Yield
  • GNLX N/A
  • RZLT N/A
  • EPS Growth
  • GNLX N/A
  • RZLT N/A
  • EPS
  • GNLX N/A
  • RZLT N/A
  • Revenue
  • GNLX $8,000.00
  • RZLT N/A
  • Revenue This Year
  • GNLX N/A
  • RZLT N/A
  • Revenue Next Year
  • GNLX N/A
  • RZLT N/A
  • P/E Ratio
  • GNLX N/A
  • RZLT N/A
  • Revenue Growth
  • GNLX N/A
  • RZLT N/A
  • 52 Week Low
  • GNLX $1.60
  • RZLT $0.72
  • 52 Week High
  • GNLX $16.60
  • RZLT $6.19
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 55.06
  • RZLT 66.20
  • Support Level
  • GNLX $2.86
  • RZLT $5.51
  • Resistance Level
  • GNLX $3.03
  • RZLT $6.03
  • Average True Range (ATR)
  • GNLX 0.26
  • RZLT 0.35
  • MACD
  • GNLX -0.02
  • RZLT 0.03
  • Stochastic Oscillator
  • GNLX 50.93
  • RZLT 79.59

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Share on Social Networks: